Independent provider comparison

Updated October 8, 2026

Embody vs Sprout Health: Costs, care and treatment fit

A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.

Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.

By Iacob Pastina, Independent Researcher & Publisher
Updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
37 provider profiles in our comparison·Independent researchHow we rank →

The short decision

Which should you choose?

We would start with Embody if your priority is a lower published one-month price for a clinician-approved compounded injection. Sprout Health is worth comparing if its care service and renewal options fit you. Embody's one-month semaglutide catalogue plan is $79; Sprout's shortest semaglutide plan is $149 every 4 weeks. Those are different billing periods. Before choosing Sprout, use its plan breakdown below to compare the commitment and prescribed product. Both offer online clinical review, and neither guarantees that you will qualify.

Both providers pay us a commission through our links. That relationship does not change the treatment facts or the price comparison. How we make money.

Sources: Embody catalogue · Sprout compounded plans and billing intervals

Embody logo

Embody

Assessment limited
7.3/10

This published score has not been reconciled with its recorded evidence. A direct numerical comparison may mislead.

Our pick for the lower one-month injection entry

Visit Embody
Sprout Health logo

Sprout Health

Legacy assessment
5.8/10

This score comes from an earlier or incomplete assessment. It does not establish that this program is better or worse than another.

Compare Sprout's compounded plans and care setup

Visit Sprout Health

Side by side

Embody vs Sprout Health at a glance

Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.

FeatureEmbodySprout Health

Why each one

Embody

The reviewed injection catalogue publishes four plan lengths and their prices for both molecules. Separate promotions and the published terms do not consistently describe the same offer, so confirm the applicable commitment and renewal before paying.

Sprout Health

Assigned-clinician messaging and advertised dose-flat compounded pricing, with annual prepayment or shorter plans billed in four-week intervals.
Published Assessment7.3/10 Assessment limited5.8/10 Legacy assessment

Assessment limits

Embody

This published score has not been reconciled with its recorded evidence. A direct numerical comparison may mislead.

Sprout Health

This score comes from an earlier or incomplete assessment. It does not establish that this program is better or worse than another.
Headline Pricefrom $69/mofrom $99/mo
Medication TypeCompoundedCompounded
Insurance AcceptedNoNo

Best For

Embody

People who want to compare Embody's published plan menu with its separate monthly promotion and will confirm the exact charge, term and refund rules before paying

Sprout Health

Users who want a low compounded rate with the price locked as the dose rises, and who will judge service quality in month one

Watch out for

Embody

Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date.

Sprout Health

The $99/mo semaglutide rate requires $1,188 upfront for 12 months; the shorter $149 plan bills every 4 weeks, not once per calendar month
Get startedVisit EmbodyVisit Sprout Health

For Embody's one-month prices, prepaid totals and conflicting billing terms, read the Embody price and payment breakdown.

Trade-offs

Strengths and cautions compared

Embody

Pros

  • +The reviewed injection catalogue publishes four price tiers for each molecule: semaglutide $79/$76/$73/$69 and tirzepatide $129/$126/$123/$119 across one, three, six and twelve months. Separate promotional offers and published terms differ; confirm which terms govern your purchase.
  • +One-month injection prices of $79 for semaglutide and $129 for GLP-1 + GIP were visible in Embody's catalogue on September 20, 2026. The FAQ says the selected rate holds within the chosen plan.
  • +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.

2 more documented strengths

  • +Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and limited medical-disqualification refund exception are readable before you pay.
  • +Publishes responses to customer reviews on Trustpilot, giving readers the company's reply alongside individual complaints.

Cons

  • −Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date.
  • −The public catalogue shows $69/$119 as twelve-month equivalents paid up front at $828/$1,428, while a separate promotion advertises those amounts monthly. Embody's April-dated terms still list different introductory and fixed-price programs. We have not verified which terms govern the final offer. Confirm the first charge, recurring charge and commitment before paying.
  • −Trustpilot showed 3.8 / 5 across 9,425 reviews on October 8, 2026, while the landing page advertised 4.8 on our prior check. The Trustpilot profile includes merged reviews from another profile, and individual reports cover different pricing periods. It is not a measure of clinical quality.

3 more documented cautions

  • −Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
  • −The reviewed public catalogue lists compounded injections; no current branded Wegovy, Zepbound, Mounjaro or Ozempic offer was verified there.
  • −Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others. Embody and SnagRx both advertise $69 semaglutide and $119 tirzepatide, but their verified payment commitments differ. Read our SnagRx review, then compare Embody and SnagRx side by side.

Sprout Health

Pros

  • +Publishes the upfront amount and renewal interval for annual and shorter compounded plans
  • +Each patient gets an assigned licensed clinician, with clinical messaging inside the account and a short check in before every refill
  • +The advertised compounded-plan price does not rise as the prescribed dose does, and provider review, medication, shipping and telehealth support are included

Cons

  • −The $99/mo semaglutide rate requires $1,188 upfront for 12 months; the shorter $149 plan bills every 4 weeks, not once per calendar month
  • −No insurance accepted or billed, and no HSA, FSA or superbill information is shown on the site's product, FAQ, terms or refund pages (rendered check 2026-09-03)

What makes Sprout worth considering?

Sprout's current public offer lists compounded semaglutide and tirzepatide injections, with an online assessment and a licensed provider deciding whether treatment is appropriate. Current brand-name availability is not confirmed. Its public site says plans renew automatically and that billing frequency and cancellation terms appear before checkout.

Sprout's current compounded offer lists semaglutide at a $99 monthly equivalent with $1,188 billed every 12 months, or $149 every 4 weeks on the shortest plan. Tirzepatide is $149 per month equivalent with $1,788 billed annually, or $199 every 4 weeks. The upfront amount and billing period are part of the comparison, not optional fine print. The offer includes provider review, medication and shipping, subject to clinical approval.

Sources: Sprout programs and published prices · Sprout plan and care review

When would we recommend Embody instead?

For the same one-month shopping task, Embody publishes the lower semaglutide entry. Its catalogue also shows exactly how an annual upfront payment lowers the monthly equivalent. Start with one month if you want to limit your initial commitment, then compare longer terms only if they fit your needs.

Compounded medicines are not FDA approved. A clinician must decide whether an approved medicine can meet your needs and whether a compounded preparation is appropriate. Embody's payments are normally non-refundable, with a limited provider-determined medical-disqualification exception; that matters when choosing a prepaid term.

Sources: Embody catalogue · Embody refund policy · FDA compounding guidance

Keep narrowing the decision

What should you compare next?

Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.

Try Embody

Headline price: from $69/mo

Visit Embody

Try Sprout Health

Headline price: from $99/mo

Visit Sprout Health

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is Embody legit, with the verification evidence behind each answer.